# Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension

> **NCT02202525** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 2148 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Micardis®
- **DRUG:** Other hypertensives

## Key facts

- **NCT ID:** NCT02202525
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2002-03
- **Final completion:** —
- **Target enrollment:** 2148 (ACTUAL)
- **Last updated:** 2014-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202525, "Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02202525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*